Briefing: Here is Why CRISPR Therapeutics (CRSP) Appears so Good
Strategic angle: An analysis of CRISPR Therapeutics' potential in the market.
Editorial Staff Mar 10
All Articles
Browse the full archive, newest first.
Briefing: Wedbush Reaffirms Outperform Rating for Tango Therapeutics (TNGX)
Strategic angle: Wedbush maintains a positive outlook on Tango Therapeutics, signaling confidence in its performance.
Editorial Staff Mar 10
Briefing: What role does the US base in Germany's Ramstein play in Iran war?
Strategic angle: The US airbase in Ramstein is crucial for coordinating US intervention in the Iran war, despite Germany's stance of neutrality.
Editorial Staff Mar 10
Briefing: Lebanon calls for talks with Israel on plan to end Hezbollah conflict
Strategic angle: President Aoun outlines a path towards "permanent security and stability", as Israeli strikes targeting Hezbollah continue.
Editorial Staff Mar 10
Briefing: Stellantis Taps Toyota, Bosch Suppliers for Hybrid Technologies for New Jeeps
Strategic angle: Jeep maker Stellantis is leaning on technologies from automotive suppliers for its newest hybrid vehicles, CNBC has learned.
Editorial Staff Mar 10
Briefing: Large drugmakers are developing fewer antibiotics, analysis finds
Strategic angle: The number of potential antimicrobial treatments being developed by the world’s largest drugmakers nosedived by 35% over the past five years, according to a new analysis.
Editorial Staff Mar 10